RNA Origami Functions as a Self-Adjuvanted Nanovaccine Platform for Cancer Immunotherapy

Scientists demonstrated that the assembled RNA-OG-peptide nanovaccines induced dendritic cell maturation, reduced tumor-mediated immunosuppression, and mobilized tumor-specific CD8+ T cell responses at the tumor site.